Orange Book product · Generic (ANDA)
FOSCARNET SODIUM
FOSCARNET SODIUM
At a glance
Mar 01, 2024
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 01, 2024
2 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
FOSCARNET SODIUM
Strength
6GM/250ML (24MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
AP
Application
ANDA 216602
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FOSCARNET SODIUM
- 1991FOSCAVIRBrand (NDA)
NDA 020068 · CLINIGEN HLTHCARE
- 2026FOSCARNET SODIUMGeneric (ANDA)
ANDA 220068 · CAPLIN
- 2023FOSCARNET SODIUMGeneric (ANDA)
ANDA 213987 · SCIECURE
- 2023FOSCARNET SODIUMGeneric (ANDA)
ANDA 213807 · AVET LIFESCIENCES
- 2021FOSCARNET SODIUMGeneric (ANDA)
ANDA 213001 · GLAND
- 2021FOSCARNET SODIUMGeneric (ANDA)
ANDA 212483 · FRESENIUS KABI USA
- 2005FOSCARNET SODIUMGeneric (ANDA)
ANDA 077174 · HOSPIRA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
